➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Colorcon
Medtronic
Express Scripts
McKesson

Last Updated: October 25, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR COCAINE HYDROCHLORIDE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Cocaine Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000187 Ritanserin in Treatment of Cocaine Dependence - 1 Completed National Institute on Drug Abuse (NIDA) Phase 2 1992-07-01 The purpose of this study is to assess ritanserin as a pharmacotherapy for cocaine dependence.
NCT00000187 Ritanserin in Treatment of Cocaine Dependence - 1 Completed University of Pennsylvania Phase 2 1992-07-01 The purpose of this study is to assess ritanserin as a pharmacotherapy for cocaine dependence.
NCT00000188 Selegiline in Treatment of Cocaine Dependence - 2 Completed National Institute on Drug Abuse (NIDA) Phase 2 1994-09-01 The purpose of this study is to assess selegiline as a pharmacotherapy for cocaine dependence.
NCT00000188 Selegiline in Treatment of Cocaine Dependence - 2 Completed University of Pennsylvania Phase 2 1994-09-01 The purpose of this study is to assess selegiline as a pharmacotherapy for cocaine dependence.
NCT00000189 Gepirone vs Placebo in Treatment of Cocaine Dependence - 3 Completed National Institute on Drug Abuse (NIDA) Phase 2 1990-01-01 The purpose of this study is to test antidepressant medication, gepirone, as a pharmacotherapy for cocaine dependent subjects.
NCT00000189 Gepirone vs Placebo in Treatment of Cocaine Dependence - 3 Completed University of Pennsylvania Phase 2 1990-01-01 The purpose of this study is to test antidepressant medication, gepirone, as a pharmacotherapy for cocaine dependent subjects.
NCT00000191 Carbamazepine Treatment for Cocaine Dependence - 5 Completed National Institute on Drug Abuse (NIDA) Phase 2 1991-01-01 The purpose of this study is to assess carbamazepine as a pharmacotherapy for cocaine dependence.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Cocaine Hydrochloride

Condition Name

Condition Name for Cocaine Hydrochloride
Intervention Trials
Cocaine-Related Disorders 141
Cocaine Dependence 134
Cocaine Abuse 25
Substance-Related Disorders 23
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Cocaine Hydrochloride
Intervention Trials
Cocaine-Related Disorders 308
Disease 67
Substance-Related Disorders 50
Opioid-Related Disorders 23
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Cocaine Hydrochloride

Trials by Country

Trials by Country for Cocaine Hydrochloride
Location Trials
United States 488
Canada 11
Brazil 8
Germany 6
Spain 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Cocaine Hydrochloride
Location Trials
Texas 66
New York 52
Connecticut 46
Pennsylvania 44
Maryland 38
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Cocaine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Cocaine Hydrochloride
Clinical Trial Phase Trials
Phase 4 24
Phase 3 27
Phase 2/Phase 3 17
[disabled in preview] 312
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Cocaine Hydrochloride
Clinical Trial Phase Trials
Completed 267
Recruiting 78
Unknown status 35
[disabled in preview] 60
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Cocaine Hydrochloride

Sponsor Name

Sponsor Name for Cocaine Hydrochloride
Sponsor Trials
National Institute on Drug Abuse (NIDA) 279
Yale University 45
New York State Psychiatric Institute 40
[disabled in preview] 85
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Cocaine Hydrochloride
Sponsor Trials
Other 446
NIH 293
Industry 37
[disabled in preview] 25
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Harvard Business School
Johnson and Johnson
Moodys
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.